A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments
Public ClinicalTrials.gov record NCT01529112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral E7080 in Addition to Best Supportive Care (BSC) Versus BSC Alone in Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Who Have Failed at Least Two Systemic Anticancer Regimens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the overall survival of patients receiving E7080 + Best Supportive Care (BSC) with those receiving placebo + Best Supportive Care.
Study identification
- NCT ID
- NCT01529112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Actual)
- Primary completion
- Jan 21, 2014 (Actual)
- Completion
- Jun 27, 2015 (Actual)
- Last update posted
- Sep 26, 2017
2011 – 2015
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Donald W. Hill, M.D., F.A.C.P. | Casa Grande | Arizona | 85122 | — |
| Arizona Oncology Associates , PC - HOPE | Tucson | Arizona | 85710 | — |
| Ronald Yanagihara, MD 9360 North Name Uno Suite 130 Gilroy California 95020 | Gilroy | California | 95020 | — |
| Ocala Oncology Center, P.L. | Ocala | Florida | 34471 | — |
| Washington University 660 South Euclid Avenue Campus Box 8124 St Louis Missouri 63110 | St Louis | Missouri | 63110 | — |
| New York Oncology Heamatology - Latham | Clifton Park | New York | 12065 | — |
| Montefiore Medical Park 1695 Easchester Road Floor 1 Bronx, NY 10461 | New York | New York | 10467 | — |
| Cancer Treatment and Research Centre Bismarck North Dakota 58501 | Bismarck | North Dakota | 58501 | — |
| Texas Oncology, P.A. - Paris | Paris | Texas | 75460 | — |
| Texas Oncology, P.A. - Plano | Plano | Texas | 75093 | — |
| Texas Oncology, P.A. - Waco | Waco | Texas | 76712 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01529112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2017 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01529112 live on ClinicalTrials.gov.